Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$84.12 – $104.61
0% from low
Exchange
OTC Link
OS
SIEGFRIED HLDGS LTD NEW
No one on the platform currently holds SGFEF.
No tracked institution reports a position in SGFEF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-28 | $0.4000 | 2026-04-30 |
| 2025-04-22 | $3.8000 | 2025-04-24 |
| Execution date | Ratio |
|---|---|
| 2025-04-29 | 10-for-1 |
No one on the platform has traded SGFEF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.4B | +3.4% | $4.01 | $3.91–$4.14 | 21.0× | 1 |
| 2027 | $1.5B | +9.5% | $4.60 | $4.49–$4.75 | 18.3× | 1 |
| 2028 | $1.6B | +7.1% | $5.09 | $4.97–$5.26 | 16.5× | 1 |
| 2029 | $1.7B | +5.0% | $5.50 | $5.36–$5.68 | 15.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-20 | $2.73 | $2.78 | +1.8% |
| 2025-06-30 | $1.94 | $1.89 | -2.6% |
| 2025-02-18 | $2.26 | $22.50 | +895.6% |
| 2024-08-22 | $1.71 | $18.50 | +981.9% |
| 2024-04-18 | $2.20 | $7.72 | +250.9% |
| 2023-06-30 | $1.52 | $14.48 | +852.6% |
| 2022-12-31 | $1.81 | $23.54 | +1200.6% |
| 2022-06-30 | $1.00 |
| $15.15 |
| +1419.6% |
| $4.7B |
| — |
| HKMPYHikma Pharmaceuticals PLC | $45.35 | -1.86% | $4.7B | — |
| HLUBFH. Lundbeck A/S | $5.54 | +2.08% | $5.9B | — |
Source: Financial Modeling Prep · peers by sector/industry